Implantable device curbs seizures and improves cognition in epileptic rats

Implantable device curbs seizures and improves cognition in epileptic rats
Schematic of a clinical sized device showing its main components and function. The right, cut-out view shows the cells within the device. Credit: Giovanna Paolone

A protein-secreting device implanted into the hippocampus of epileptic rats reduces seizures by 93 percent in three months, finds preclinical research published in JNeurosci. These results support ongoing development of this technology and its potential translation into a new treatment for epilepsy.

Motivated by an unmet need for effective and well-tolerated therapies, Giovanna Paolone and colleagues of the University of Ferrara, Italy and of Gloriana Therapeutics, Inc. (Providence, RI) investigated the effects of the Gloriana targeted cellular delivery system for glial cell line-derived (GDNF)—a protein recent research suggests may help suppress epileptic activity.

In addition to quickly and progressively reducing seizures in —by 75 percent within two weeks—the researchers found their device improved rats' anxiety-like symptoms and their performance on an object recognition task, indicating improvement in cognition.

The treatment also corrected abnormalities in brain anatomy associated with epilepsy. These effects persisted even after the device was removed, indicating this approach may modify the disease progression.

Implantable device curbs seizures and improves cognition in epileptic rats
GDNF releasing cells reduce epilepsy induced cell death. In a normal hippocampus (A) no overt sign of cell death can be observed, whereas many dying cells (stained in green) are observed in the epileptic hippocampus (B). GDNF releasing cells effectively attenuate cell death (C). Credit: Giovanna Paolone

Explore further

Adenosine therapy reduces seizures and progression of epilepsy

More information: Long-Term, Targeted Delivery of GDNF From Encapsulated Cells is Neuroprotective and Reduces Seizures, JNeurosci (2019). DOI: 10.1523/JNEUROSCI.0435-18.2018
Provided by Society for Neuroscience
Citation: Implantable device curbs seizures and improves cognition in epileptic rats (2019, January 21) retrieved 20 February 2019 from https://medicalxpress.com/news/2019-01-implantable-device-curbs-seizures-cognition.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more